Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

[Mechanisms of action of Alzheimer medications].

Alhainen K.

Duodecim. 2003;119(20):1959-66. Review. Finnish. No abstract available.

PMID:
14640001
2.

Usefulness of repeated presentation of Mini-Mental State Examination as a diagnostic procedure--a population-based study.

Helkala EL, Kivipelto M, Hallikainen M, Alhainen K, Heinonen H, Tuomilehto J, Soininen H, Nissinen A.

Acta Neurol Scand. 2002 Dec;106(6):341-6.

PMID:
12460138
3.

Midlife income, occupation, APOE status, and dementia: a population-based study.

Anttila T, Helkala EL, Kivipelto M, Hallikainen M, Alhainen K, Heinonen H, Mannermaa A, Tuomilehto J, Soininen H, Nissinen A.

Neurology. 2002 Sep 24;59(6):887-93.

PMID:
12297572
4.

Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.

Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, Iivonen S, Mannermaa A, Tuomilehto J, Nissinen A, Soininen H.

Ann Intern Med. 2002 Aug 6;137(3):149-55.

PMID:
12160362
5.

Tacrine may alter APP-like protein levels in the lumbar CSF of Alzheimer patients.

Clarke NA, Soininen H, Gustafson L, Minthon L, Alhainen K, Francis PT.

Int J Geriatr Psychiatry. 2001 Nov;16(11):1104-6. No abstract available.

PMID:
11746658
6.

Socioeconomic status and ischemic stroke: The FINMONICA Stroke Register.

Jakovljević D, Sarti C, Sivenius J, Torppa J, Mähönen M, Immonen-Räihä P, Kaarsalo E, Alhainen K, Kuulasmaa K, Tuomilehto J, Puska P, Salomaa V.

Stroke. 2001 Jul;32(7):1492-8.

PMID:
11441191
7.

Socioeconomic inequalities in the incidence, mortality and prognosis of subarachnoid hemorrhage: the FINMONICA Stroke Register.

Jakovljević D, Sivenius J, Sarti C, Torppa J, Mähönen M, Immonen-Räihä P, Kaarsalo E, Alhainen K, Tuomilehto J, Puska P, Salomaa V.

Cerebrovasc Dis. 2001;12(1):7-13.

PMID:
11435673
8.

Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study.

Kivipelto M, Helkala EL, Hänninen T, Laakso MP, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A.

Neurology. 2001 Jun 26;56(12):1683-9.

PMID:
11425934
9.

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study.

Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A.

BMJ. 2001 Jun 16;322(7300):1447-51.

10.

Socioeconomic differences in the incidence, mortality and prognosis of intracerebral hemorrhage in Finnish Adult Population. The FINMONICA Stroke Register.

Jakovljevic D, Sarti C, Sivenius J, Torppa J, Mähönen M, Immonen-Räihä P, Kaarsalo E, Alhainen K, Tuomilehto J, Puska P, Salomaa V.

Neuroepidemiology. 2001 May;20(2):85-90.

PMID:
11359074
11.

Trends in case-fatality of stroke in Finland during 1983 to 1992.

Immonen-Räihä P, Mähönen M, Tuomilehto J, Salomaa V, Kaarsalo E, Narva EV, Salmi K, Sarti C, Sivenius J, Alhainen K, Torppa J.

Stroke. 1997 Dec;28(12):2493-9.

PMID:
9412639
12.

[Narcolepsy--an unusual cause of abnormal sleepiness in children].

Hublin C, Nuutila A, Alhainen K, Saarenpää-Heikkilä O.

Duodecim. 1995;111(12):1165-70. Review. Finnish. No abstract available.

PMID:
9213554
13.

Electrophysiological and neuropsychological effects of a central alpha 2-antagonist atipamezole in healthy volunteers.

Mervaala E, Alhainen K, Helkala EL, Partanen J, Jousmäki V, Väyrynen M, Heinonen E, Riekkinen P.

Behav Brain Res. 1993 May 31;55(1):85-91.

PMID:
8101086
14.

Psychometric discrimination of tetrahydroaminoacridine responders in Alzheimer patients.

Alhainen K, Helkala EL, Riekkinen P.

Dementia. 1993 Jan-Feb;4(1):54-8.

PMID:
8358507
15.

Discrimination of Alzheimer patients responding to cholinesterase inhibitor therapy.

Alhainen K, Riekkinen PJ Sr.

Acta Neurol Scand Suppl. 1993;149:16-21.

PMID:
7907454
16.

The relationship of cerebrospinal fluid monoamine metabolites with clinical response to tetrahydroaminoacridine in patients with Alzheimer's disease.

Alhainen K, Helkala EL, Reinikainen K, Riekkinen P Sr.

J Neural Transm Park Dis Dement Sect. 1993;5(3):185-92.

PMID:
7690228
17.
18.

Discrimination of tetrahydroaminoacridine responders by a single dose pharmaco-EEG in patients with Alzheimer's disease.

Alhainen K, Partanen J, Reinikainen K, Laulumaa V, Soininen H, Airaksinen M, Riekkinen P.

Neurosci Lett. 1991 Jun 10;127(1):113-6.

PMID:
1881606

Supplemental Content

Loading ...
Support Center